검색
10X Genomics Inc
TXG관심 목록에 추가
70.110USD
+1.520+2.22%
종가 09-14 16:00（ET）
9.14B시가총액
손실P/E TTM
자세한 내용은 10X Genomics Inc 회사
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
10X Genomics Inc 프로필
종목 코드 TXG
회사 이름10X Genomics Inc
상장일Sep 12, 2019
CEOSaxonov (Serge Wilson)
직원 수1306
유형Ordinary Share
회계 연도 종료Sep 12
주소6230 Stoneridge Mall Road
도시PLEASANTON
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호94588
전화19254017300
웹사이트https://www.10xgenomics.com/
종목 코드 TXG
상장일Sep 12, 2019
CEOSaxonov (Serge Wilson)
10X Genomics Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Serge Wilson Saxonov, Ph.D.
Mr. Serge Wilson Saxonov, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
1.07M
-0.01%
Mr. Serge Wilson Saxonov, Ph.D.
Mr. Serge Wilson Saxonov, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
1.07M
-0.01%
Dr. John R. Stuelpnagel
Dr. John R. Stuelpnagel
Independent Chairman of the Board
Independent Chairman of the Board
358.44K
-5.58%
Dr. John R. Stuelpnagel
Dr. John R. Stuelpnagel
Independent Chairman of the Board
Independent Chairman of the Board
358.44K
-5.58%
Whitaker (Eric S)
Whitaker (Eric S)
Chief Legal Officer
Chief Legal Officer
202.20K
+22.53%
Dr. Benjamin J. Hindson, Ph.D.
Dr. Benjamin J. Hindson, Ph.D.
President, Co-Founder, Chief Scientific Officer, Director
President, Co-Founder, Chief Scientific Officer, Director
91.41K
-15.12%
Dr. Benjamin J. Hindson, Ph.D.
Dr. Benjamin J. Hindson, Ph.D.
President, Co-Founder, Chief Scientific Officer, Director
President, Co-Founder, Chief Scientific Officer, Director
91.41K
-15.12%
Mr. Sridhar (Sri) Kosaraju
Mr. Sridhar (Sri) Kosaraju
Independent Director
Independent Director
68.28K
+12.93%
Mr. Sridhar (Sri) Kosaraju
Mr. Sridhar (Sri) Kosaraju
Independent Director
Independent Director
68.28K
+12.93%
Ms. Kimberly J. (Kim) Popovits
Ms. Kimberly J. (Kim) Popovits
Independent Director
Independent Director
37.45K
+23.58%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Serge Wilson Saxonov, Ph.D.
Mr. Serge Wilson Saxonov, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
1.07M
-0.01%
Mr. Serge Wilson Saxonov, Ph.D.
Mr. Serge Wilson Saxonov, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
1.07M
-0.01%
Dr. John R. Stuelpnagel
Dr. John R. Stuelpnagel
Independent Chairman of the Board
Independent Chairman of the Board
358.44K
-5.58%
Dr. John R. Stuelpnagel
Dr. John R. Stuelpnagel
Independent Chairman of the Board
Independent Chairman of the Board
358.44K
-5.58%
Whitaker (Eric S)
Whitaker (Eric S)
Chief Legal Officer
Chief Legal Officer
202.20K
+22.53%
Dr. Benjamin J. Hindson, Ph.D.
Dr. Benjamin J. Hindson, Ph.D.
President, Co-Founder, Chief Scientific Officer, Director
President, Co-Founder, Chief Scientific Officer, Director
91.41K
-15.12%
자주 묻는 질문
10X Genomics Inc의 상위 5대 주주는 누구인가요?
10X Genomics Inc의 상위 5대 주주는 다음과 같습니다: Mr. Serge Wilson Saxonov, Ph.D.
10X Genomics Inc(TXG)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, 10X Genomics Inc의 주식을 보유한 기관은 총 726곳이며, 이들이 보유한 주식의 총 가치는 약 140.84M로 전체 발행 주식의 118.45%를 차지합니다. 이는 2025Q4 대비 -2946322.00 증가한 수치입니다.
10X Genomics Inc의 최대 수익원은 무엇인가요?
2026Q1 기준, 10X Genomics Inc의 Consumables 부문이 가장 높은 매출을 기록했으며, 금액은 130.75M로 전체 매출의 86.57%를 차지했습니다.